PPARGC1A and Parkinson disease: Since the underexpression of a geneset of PGC-1α–responsive genes was significantly associated with PD pathology in this meta-analysis, the authors investigated PGC-1α over-expression as a new therapeutic strategy and reported that it suppressed dopaminergic neuron loss in two cell culture models of PD (Zheng et al. 2010).